These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24488656)

  • 1. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
    Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
    J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
    Ma C; Chen L; Scheenen TW; Lu J; Wang J
    Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible proton 3D MR spectroscopic imaging of the prostate with low-power adiabatic pulses for volume selection and spiral readout.
    Steinseifer IK; Philips BW; Gagoski B; Weiland E; Scheenen TW; Heerschap A
    Magn Reson Med; 2017 Mar; 77(3):928-935. PubMed ID: 26968422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
    Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy.
    Nagarajan R; Iqbal Z; Burns B; Wilson NE; Sarma MK; Margolis DA; Reiter RE; Raman SS; Thomas MA
    NMR Biomed; 2015 Nov; 28(11):1366-73. PubMed ID: 26346702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
    Weis J; Ortiz-Nieto F; Ahlström H
    Magn Reson Med Sci; 2013 Dec; 12(4):289-96. PubMed ID: 24172792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
    Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
    Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
    Wright AJ; Buydens LM; Heerschap A
    NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
    Styles C; Ferris N; Mitchell C; Murphy D; Frydenberg M; Mills J; Pedersen J; Bergen N; Duchesne G
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):439-48. PubMed ID: 24935089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.